A Phase 2/3 Randomized, Open-Label Study of Toca 511, a

Project: Research project

Project Details

Description

A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
StatusActive
Effective start/end date11/1/1711/30/20

Funding

  • Tocagen Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.